Vixarelimab in Patients With Prurigo Nodularis
Authors
- Gil Yosipovitch (ORCID: https://orcid.org/0000-0001-6303-1822)
- Sonja Ständer (ORCID: https://orcid.org/0000-0003-3612-7786)
- John F. Paolini (ORCID: https://orcid.org/0000-0001-7622-8851)
- Joshua Galanter (ORCID: https://orcid.org/0000-0002-2561-6384)
- Howard Sofen (ORCID: https://orcid.org/0000-0001-7789-6915)
- Sheldon Wang
- Daniel Abramzon
Institutions
- University of Miami (US)
- University Hospital Münster (DE)
- Synta Pharmaceuticals (United States) (US)
Funders
- Amgen
- Eli Lilly and Company
- GlaxoSmithKline
- Sanofi
- Regeneron Pharmaceuticals
- Celldex Therapeutics
- Kiniksa Pharmaceuticals
- Galderma
- LEO Pharma
- Genentech